Palatin Technologies
Utility Patents

Last updated:

List of all Palatin Technologies patents 3 in total

Status Patent
Grant
Utility: Melanocortin receptor-specific peptide with C-terminal naphthylalanine External link
Filling date: 9 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Therapies for obesity, diabetes and related indications External link
Filling date: 9 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Melanocortin receptor-specific peptides External link
Filling date: 9 Sep 2025 Issue date: 28 Apr 2020

Showing 1 to 3 of 3 patents.